Gå direkt till innehåll


Martin Olovsson

Martin Olovsson

Presskontakt CEO Ondosis +46 76-772 85 01

Relaterat innehåll

OnDosis – Changing the game, one dose at a time

Founded as a spin-out from AstraZeneca in 2017, OnDosis is a Swedish start-up addressing one of the major opportunities in healthcare; personalized dosage of medicines. The proprietary technology platform is centered around a connected handheld dosing device that delivers tailored doses of oral medicines. By combining individual dosing of traditional drug-based medicines augmented by digital therapeutics, OnDosis opens a new chapter in personalized medicine where the mission is to improve patients’ life through delivering the perfect dosage; individualized, intuitive, and intelligent.

OnDosis AB
Pepparedsleden 1
431 50 Mölndal